http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 17:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html <p align="justify">BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) under the symbol “ZN0”, WKN: A42EHA, and ISIN: CA CA40173G1019.</p> <p align="justify">The Company’s common shares are now listed for trading on Cboe Canada and posted to the FSE, offering increased international exposure to both Canadian and European investors. The Company’s FSE stock quote can be accessed here: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=81Gl5Xrh0YfQbS5TS_LQkBuprm2xVi_f8TZjg5k_BKHmEaxSbWJmD7iYkUMWvyjunrXwDO1dF_ZtWUa3EWwZv8gG9UDn9dDC4RVktnz5DP-5IunNXhgNkKcuD5Z7TLlnA02J6bb4wzH6Qau32SJPzax92z0mxkNqaNH_5BCRfMru9039B0N3MfQDEaKndLJkM2oigWDO5CvK0yqTHHCG8w==" rel="nofollow" target="_blank">https://live.deutsche-boerse.com/equity/guide-ai-health-o-n</a>.</p> <p align="justify">The company also announces that it has http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html Fri, 14 Aug 2026 17:00:00 -0400 GDAI ZN0 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html <p align="justify">BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) under the symbol “ZN0”, WKN: A42EHA, and ISIN: CA CA40173G1019.</p> <p align="justify">The Company’s common shares are now listed for trading on Cboe Canada and posted to the FSE, offering increased international exposure to both Canadian and European investors. The Company’s FSE stock quote can be accessed here: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=81Gl5Xrh0YfQbS5TS_LQkBuprm2xVi_f8TZjg5k_BKHmEaxSbWJmD7iYkUMWvyjunrXwDO1dF_ZtWUa3EWwZv8gG9UDn9dDC4RVktnz5DP-5IunNXhgNkKcuD5Z7TLlnA02J6bb4wzH6Qau32SJPzax92z0mxkNqaNH_5BCRfMru9039B0N3MfQDEaKndLJkM2oigWDO5CvK0yqTHHCG8w==" rel="nofollow" target="_blank">https://live.deutsche-boerse.com/equity/guide-ai-health-o-n</a>.</p> <p align="justify">The company also announces that it has http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html Fri, 14 Aug 2026 17:00:00 -0400 GDAI ZN0 http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html <p align="justify">BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) under the symbol “ZN0”, WKN: A42EHA, and ISIN: CA CA40173G1019.</p> <p align="justify">The Company’s common shares are now listed for trading on Cboe Canada and posted to the FSE, offering increased international exposure to both Canadian and European investors. The Company’s FSE stock quote can be accessed here: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=81Gl5Xrh0YfQbS5TS_LQkBuprm2xVi_f8TZjg5k_BKHmEaxSbWJmD7iYkUMWvyjunrXwDO1dF_ZtWUa3EWwZv8gG9UDn9dDC4RVktnz5DP-5IunNXhgNkKcuD5Z7TLlnA02J6bb4wzH6Qau32SJPzax92z0mxkNqaNH_5BCRfMru9039B0N3MfQDEaKndLJkM2oigWDO5CvK0yqTHHCG8w==" rel="nofollow" target="_blank">https://live.deutsche-boerse.com/equity/guide-ai-health-o-n</a>.</p> <p align="justify">The company also announces that it has http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html Fri, 14 Aug 2026 17:00:00 -0400 GDAI ZN0 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html <p align="justify">BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) under the symbol “ZN0”, WKN: A42EHA, and ISIN: CA CA40173G1019.</p> <p align="justify">The Company’s common shares are now listed for trading on Cboe Canada and posted to the FSE, offering increased international exposure to both Canadian and European investors. The Company’s FSE stock quote can be accessed here: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=81Gl5Xrh0YfQbS5TS_LQkBuprm2xVi_f8TZjg5k_BKHmEaxSbWJmD7iYkUMWvyjunrXwDO1dF_ZtWUa3EWwZv8gG9UDn9dDC4RVktnz5DP-5IunNXhgNkKcuD5Z7TLlnA02J6bb4wzH6Qau32SJPzax92z0mxkNqaNH_5BCRfMru9039B0N3MfQDEaKndLJkM2oigWDO5CvK0yqTHHCG8w==" rel="nofollow" target="_blank">https://live.deutsche-boerse.com/equity/guide-ai-health-o-n</a>.</p> <p align="justify">The company also announces that it has http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Corp.+Announces+Frankfurt+Stock+Exchange+Symbol%3A+ZN0/26932383.html Fri, 14 Aug 2026 17:00:00 -0400 GDAI ZN0 http://www.streetinsider.com/Corporate+News/GuideAI+Health+hires+firms+for+marketing+and+investor+outreach/26757928.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has engaged two firms to conduct a marketing and investor-awareness program, according to a press release from the company.</p><p>The Boston-based healthcare technology company hired Upswitch Media Corp. to provide digital marketing and media distribution services, including content creation and distribution across online channels. The engagement begins around July 13, 2026, and may continue on a month-to-month basis. GuideAI has committed a minimum budget of CAD $500,000 for the arrangement.</p><p>GuideAI also engaged BTV-Business Television to produce and broadcast a 30-second television spot scheduled to air on BNN Bloomberg in Canada approximately 50 times per week. http://www.streetinsider.com/Corporate+News/GuideAI+Health+hires+firms+for+marketing+and+investor+outreach/26757928.html Fri, 10 Jul 2026 17:01:28 -0400 GDAI http://www.streetinsider.com/Press+Releases/GuideAI+Health+Announces+Marketing+and+Communications+Programs/26757922.html <p align="justify">BOSTON, July 10, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) is pleased to announce that it has engaged Upswitch Media Corp. (&quot;Upswitch&quot;) and BTV-Business Television (&quot;BTV&quot;) — to execute a coordinated marketing, communications and investor-awareness program (the &quot;Program&quot;). The Program is designed to raise awareness of the Company and its artificial intelligence (AI) platform for the detection and characterization of vascular disease among the news, investment and healthcare communities.</p> <p align="justify">The Program combines digital marketing and media distribution, professional corporate communications and national broadcast television advertising. Together, these engagements are http://www.streetinsider.com/Press+Releases/GuideAI+Health+Announces+Marketing+and+Communications+Programs/26757922.html Fri, 10 Jul 2026 17:01:00 -0400 GDAI http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Announces+Marketing+and+Communications+Programs/26757922.html <p align="justify">BOSTON, July 10, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) is pleased to announce that it has engaged Upswitch Media Corp. (&quot;Upswitch&quot;) and BTV-Business Television (&quot;BTV&quot;) — to execute a coordinated marketing, communications and investor-awareness program (the &quot;Program&quot;). The Program is designed to raise awareness of the Company and its artificial intelligence (AI) platform for the detection and characterization of vascular disease among the news, investment and healthcare communities.</p> <p align="justify">The Program combines digital marketing and media distribution, professional corporate communications and national broadcast television advertising. Together, these engagements are http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Announces+Marketing+and+Communications+Programs/26757922.html Fri, 10 Jul 2026 17:01:00 -0400 GDAI http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/Board+Changes/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has appointed James F. Benenati, MD, FSIR, to its advisory board, the company announced. The appointment follows the company's receipt of FDA 510(k) clearance for its VascularAssist Occlusion Triage (VAOT) software, which was announced June 22, 2026.</p> <p>VAOT is a Class II, AI-based Software as a Medical Device classified as a Computer-Aided Triage and Notification device. It is designed to assist radiologists in identifying peripheral arterial disease by flagging suspected vascular occlusion cases for prioritized review within existing imaging workflows.</p> <p>Dr. Benenati currently serves as Chief Medical Officer of Penumbra, Inc. He previously practiced interventional radiology http://www.streetinsider.com/FDA/GuideAI+Health+adds+interventional+radiology+expert+to+advisory+board/26732982.html Mon, 06 Jul 2026 08:00:50 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Press+Releases/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html <p align="justify">BOSTON, July 06, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: <strong>GDAI</strong>) (&quot;<strong>GuideAI</strong>&quot; or the &quot;<strong>Company</strong>&quot;) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VascularAssist Occlusion Triage (VAOT) (please see news release dated June 22nd, 2026), the Company’s artificial intelligence software designed to support the prioritization and triage of vascular occlusion in the lower extremities. Building on this milestone, the Company is pleased to announce the appointment of James F. Benenati, MD, FSIR, a board-certified interventional radiologist and recognized leader in vascular medicine, to its Advisory Board. Dr. Benenati brings more than http://www.streetinsider.com/Globe+Newswire/GuideAI+Health+Appoints+Renowned+Interventional+Radiologist+Dr.+James+Benenati+to+Advisory+Board+Following+FDA+510%28k%29+Clearance+of+VAOT/26732972.html Mon, 06 Jul 2026 08:00:00 -0400 A.06822034 A.23453077 GDAI O.20026344 http://www.streetinsider.com/Corporate+News/GuideAI+Health+hires+market+maker+for+Cboe+Canada+shares/26729163.html <p>GuideAI Health Corp. (Cboe CA: GDAI) has engaged DS Market Solutions Inc. as a market maker for its common shares traded on Cboe Canada, according to a press release statement.</p><p>The agreement carries an initial term of one month and renews automatically for additional one-month periods unless either party provides 30 days' prior notice of termination.</p><p>Under the arrangement, DS Market Solutions will buy and sell GuideAI shares on Cboe Canada and other alternative trading venues in accordance with Cboe Canada policies. The company will pay DS Market Solutions a monthly fee of C$6,000 for the services.</p><p>GuideAI Health Corp. is a healthcare http://www.streetinsider.com/Corporate+News/GuideAI+Health+hires+market+maker+for+Cboe+Canada+shares/26729163.html Thu, 02 Jul 2026 17:00:42 -0400 GDAI http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Engages+Market+Maker/26729131.html <p align="justify">BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: GDAI) (the “<strong>Company</strong>” or “<strong>GuideAI</strong>”) announces that it has engaged DS Market Solutions Inc. (Address: 1160 Walden Circle, Unit 6, Mississauga, ON, Canada; Contact: David Sears) (“DSM”) as a market maker for its common shares traded on Cboe Canada Inc. (“Cboe Canada”).</p> <p align="justify">The agreement with DSM is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days’ prior notice.</p> <p align="justify">DSM, as GuideAI’s market maker, aims to ensure a fair http://www.streetinsider.com/Press+Releases/GuideAI+Health+Corp.+Engages+Market+Maker/26729131.html Thu, 02 Jul 2026 17:00:00 -0400 GDAI